Document is current
Any future updates will be listed below
-
Authors
Jokinen, Vilja
Taira, Aurora
Kolterud, Åsa
Ahlgren, Isa
Palin, Kimmo
Katainen, Riku
Räisänen, Maritta
Kaasinen, Eevi
Ilves, Sini
Raitila, Anniina
Kopp Kallner, Helena
Siili, Emma
Bützow, Ralf
Heikinheimo, Oskari
Pasanen, Annukka
Karhu, Auli
Välimäki, Niko
Aaltonen, Lauri A. https://orcid.org/0000-0001-6839-4286
-
Funding
Funding for this research was provided by:
Juhani Ahon Lääketieteen Tutkimussäätiö
Ida Montinin Säätiö
Instrumentariumin Tiedesäätiö
Syöpäsäätiö
Orionin Tutkimussäätiö
Paulon Säätiö
Vetenskapsrådet (2021-02298, 2021-02298)
Research Council of Finland (352814)
Jane ja Aatos Erkon Säätiö
Sigrid Juséliuksen Säätiö (230002)
European Research Council (695727)
iCAN Digital Precision Cancer Medicine Flagship (320185)
- License Information
-
More Information
Article History
Received: 4 September 2024
Revised: 15 January 2025
Accepted: 8 February 2025
First Online: 27 February 2025
Competing interests
: The authors declare no competing interests.
: This study was approved by the Ministry of Social Affairs and Health and the National Institute for Health and Welfare (53/07/2000, THL/1071/5.05.00/2011, THL/151/5.05.00/2017, THL/1300/5.05.00/2019, THL/1849/14.6.00/2024), the Ethics Committee of the Hospital District of Helsinki and Uusimaa (133/E8/03, 408/13/03/03/2009, 177/13/03/03/2016, HUS/2509/2016), the Swedish Ethical Review Authority (2022-02783-01), and the Swedish Ethical Committee (2016/37-31/1, and 2016/2385-31/4). The patient samples were collected with a written informed consent. This study was performed in accordance with the Declaration of Helsinki.
